Trials / Conditions / CCNE1 Amplification
CCNE1 Amplification
5 registered clinical trials studyying CCNE1 Amplification — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors NCT06586957 | NiKang Therapeutics, Inc. | Phase 1 |
| Terminated | A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors NCT06264921 | NiKang Therapeutics, Inc. | Phase 1 |
| Recruiting | Study of AVZO-021 in Patients With Advanced Solid Tumors NCT05867251 | Avenzo Therapeutics, Inc. | Phase 1 / Phase 2 |
| Recruiting | Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced C NCT05735080 | Incyclix Bio | Phase 1 / Phase 2 |
| Terminated | (VELA) Study of BLU-222 in Advanced Solid Tumors NCT05252416 | Blueprint Medicines Corporation | Phase 1 |